NCT00329836

Brief Summary

This is a research study examining cutaneous allodynia and cluster headaches. Cutaneous allodynia means the feeling of pain or unpleasant sensation when normally non-painful stimuli (e.g. light touch) are applied to the skin. Many studies have been performed looking at the presence of cutaneous allodynia in patients with migraines; however, few studies have examined it in cluster headache patients. There is still much to be learned about the brain and how it functions if the investigators are to understand the underlying causes of cluster headache. It is important to explore cutaneous allodynia in cluster headache as it may help guide physicians with the care of these individuals. Sixty patients will be screened for this study. Thomas Jefferson University is the only center enrolling patients in this research study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 25, 2006

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2006

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
3.5 years until next milestone

Results Posted

Study results publicly available

August 16, 2011

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

1.5 years

First QC Date

May 24, 2006

Results QC Date

July 21, 2011

Last Update Submit

February 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of Allodynia in Subjects With Cluster Headache

    Allodynia (discomfort to normal sensation) was assessed by brushing at constant rate of 2 brushes/sec and pressure allodynia with Von Frei hairs. Outcome (discomfort) was measured on a 100 mm visual analogue scale.

    Allodynia was assessed at the screening visit

Study Arms (1)

Subjects with cluster headache

Subjects with both episodic and chronic cluster (as defined by the International Headache Society-IHS) were enrolled.

Other: There are no interventions in the observational study. The symptom of allodynia was measured.

Interventions

No intervention. Description of allodynia testing appears elsewhere in this document

Subjects with cluster headache

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with cluster headache

You may qualify if:

  • Male and female patients aged 18-75, inclusive
  • Diagnosis of cluster headache, episodic or chronic.
  • Patients with episodic CH can be either in active cluster period or not.
  • Ability to read and understand an informed consent form, where the study protocol is described.

You may not qualify if:

  • Patients with abnormal sensory findings on examination, or any known neurological disease that may affect skin sensation (peripheral neuropathy, multiple sclerosis, stroke, etc).
  • Patients who are cognitively impaired, as determined by investigator
  • Patients with significant psychiatric disorder that may affect their understanding of the study protocol and/or their cooperation with the investigators.
  • Patients who had taken an acute pain medication within 24 hours prior to allodynia testing.
  • Patients with skin diseases that may cause abnormal skin sensation.
  • Patients who had been treated with a nerve block in the 4 week period prior to allodynia testing
  • Patients who had been treated with Botulinum neurotoxin within the 4 month period prior to allodynia testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jefferson Headache Center/ Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

MeSH Terms

Conditions

Cluster Headache

Condition Hierarchy (Ancestors)

Trigeminal Autonomic CephalalgiasHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Results Point of Contact

Title
Abraham Ashkenazi, M.D./ Prinicpal Investigator
Organization
Doylestown Hospital

Study Officials

  • Abraham A. Ashkenazi, M.D.

    Jefferson Headache Center/ thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

May 24, 2006

First Posted

May 25, 2006

Study Start

August 1, 2006

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

February 28, 2025

Results First Posted

August 16, 2011

Record last verified: 2025-02

Locations